Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Dec 7;115:154462. doi: 10.1016/j.metabol.2020.154462

Reply to Vitamin D deficiency in COVID-19: mixing up cause and consequence

M Chakhtoura a,b,, G El Hajj Fuleihan a,b
PMCID: PMC7833872  PMID: 33301775

Dear Editor,

The SARS-Cov-2 tsunami has engulfed the global community into an accelerated search for preventive and therapeutic strategies to halt its devastating toll; immune modulation being the fulcrum of all. The effect of vitamin D role on innate and adaptive immunity is undisputable [1], yet its role in this viral illness is unclear [2]. While biologic plausibility supports an association between vitamin D status and COVD-19 infection, establishing causality remains elusive. It was not implied in our commentary [3]. COVID-19 patients often seek medical advice after the onset of symptoms, and past the trigger of its inflammatory cascade. We concur with Smolders et al., reverse causality is a consideration [4].

These authors show that the inoculation of 9 healthy volunteers with E.Coli-derived lipopolysaccharide, at a relatively high dose of 4 ng/kg over 4 h [5], resulted in a rise in inflammatory markers, and a concomitant drop in mean serum 25-hydroxyvitamin D (25OHD), by 2.6 ng/ml, 2–3 h later [4]. Several other small studies (N 19–90) examined changes in 25OHD in acute illnesses, using for the most part standardized assays. These included elective orthopedic [6,7], and cardiac surgery [8], acute pancreatitis [9], or shock and ICU admissions [10,11]. The drop in mean 25OHD of 1–12 ng/ml occurred during the first 48 h of admission [[6], [7], [8], [9], [10], [11]]. The response was however quite variable, some studies registering no change or an increase [9,12]. Serum 25OHD level may return to baseline within 5–14 days [6,8,9], but this return was not linked to recovery from illness [12]. Both 25OHD and 1,25OH2D decreased similarly by day 5 in one study, but while 25OHD returned to baseline, there was a subsequent overshoot in 1,25OH2D level [8].

The reasons for decrements in 25OHD level in acute illness are not clear. The association of CRP and albumin, most frequently assessed predictors for a change in 25OHD during illness, were inconsistent [[6], [7], [8], [9]]. The dilutional effects of fluids during illness [6], a drop in vitamin D binding protein (VDBP) [7], and a possible increase in 1-α hydroxylation of 25OHD [9], may all contribute. Free 25OHD may also be affected. In a study of 33 patients undergoing knee arthroplasty, levels of total and free 25OHD, and VDBP, decreased by 40% and 15%, respectively, starting day 1 post-operatively [6].

The collider effect challenges association studies, reverse causality is one of them [13]. The severity of COVID-19 infection affects the decision for hospitalization, and causal inferences in hospitalized patients might not be well-grounded [13]. A thorough assessment of the evidence available, with particular attention to matters relevant to 25OHD assays [14], reverse causality, and quality assessment, is crucial [15]. Such scrutiny provides the framework to provide guidance on vitamin D supplementation, given in a preventive or adjuvant-therapy mode, in the spectrum of COVID-19 illnesses. Well conducted observational studies will also provide the basis, when coupled with forthcoming evidence from vitamin D randomized controlled trials where vitamin D effect may be confounded by the standard use of steroids, to confirm or refute the putative role of vitamin D in Covid-19 illnesses.

Declaration of competing interest

None

References

  • 1.Koivisto O., Hanel A., Carlberg C. Key vitamin D target genes with functions in the immune system. Nutrients. 2020;12(4):1140–1158. doi: 10.3390/nu12041140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–374. doi: 10.1038/s41577-020-0311-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chakhtoura M., Napoli N., El Hajj Fuleihan G. Commentary: myths and facts on vitamin D amidst the COVID-19 pandemic. Metabolism, Clinical and Experimental. 2020;109:154276. doi: 10.1016/j.metabol.2020.154276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Smolders J, van den Ouweland J, Geven C, Pickkers P, Kox M, Vitamin D deficiency in COVID-19: mixing up cause and consequence. Metabolism, Clinical and Experimental [In Press]. [DOI] [PMC free article] [PubMed]
  • 5.Fullerton J.N., Segre E., De Maeyer R.P.H., Maini A.A.N., Gilroy D.W. Intravenous endotoxin challenge in healthy humans: an experimental platform to investigate and modulate systemic inflammation. J Vis Exp. 2016;111:53913–53921. doi: 10.3791/53913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Reid D., Toole B.J., Knox S., Talwar D., Harten J., O’Reilly D.S.J. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011;93(5):1006–1011. doi: 10.3945/ajcn.110.008490. [DOI] [PubMed] [Google Scholar]
  • 7.Waldron J.L., Ashby H.L., Cornes M.P., Bechervaise J., Razavi C., Thomas O.L. Vitamin D: a negative acute phase reactant. J Clin Pathol. 2013;66(7):620–622. doi: 10.1136/jclinpath-2012-201301. [DOI] [PubMed] [Google Scholar]
  • 8.Krishnan A., Ochola J., Mundy J., Jones M., Kruger P., Duncan E. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care. 2010;14(6):R216–R223. doi: 10.1186/cc9341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bang U.C., Novovic S., Andersen A.M., Fenger M., Hansen M.B., Jensen J.-E.B. Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res. 2011;36(4):135–141. doi: 10.3109/07435800.2011.554937. [DOI] [PubMed] [Google Scholar]
  • 10.Dayal D., Kumar S., Sachdeva N., Kumar R., Singh M., Singhi S. Fall in vitamin D levels during hospitalization in children. Int J Pediatr. 2014;2014(2014):291856–291862. doi: 10.1155/2014/291856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Braun A.B., Gibbons F.K., Litonjua A.A., Giovannucci E., Christopher K.B. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012;40(1):63–72. doi: 10.1097/CCM.0b013e31822d74f3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Barth J.H., Field H.P., Mather A.N., Plein S. Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann Clin Biochem. 2012;49(Pt 4):399–401. doi: 10.1258/acb.2011.011195. [DOI] [PubMed] [Google Scholar]
  • 13.Griffith G.J., Morris T.T., Tudball M.J., Herbert A., Mancano G., Pike L. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749–5761. doi: 10.1038/s41467-020-19478-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Heijboer A., Blankenstein M., Kema I., Buijs M. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem. 2012;58(3):543–548. doi: 10.1373/clinchem.2011.176545. [DOI] [PubMed] [Google Scholar]
  • 15.Bassatne A., Basbous M., Chakhtoura M., Rahme M., El Zein O., El-Hajj Fuleihan G. The link between corona vIruses and VItamin D (VIVID): an extensive and rigorous systematic review and meta-analysis. 2020. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=203960 Available from.

Articles from Metabolism are provided here courtesy of Elsevier

RESOURCES